✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CopdCbdRespiratoryAnti-InflammatoryPatient Experience Why This MattersCOPD patients increasingly ask about CBD for symptom management, particularly...
Kana CBD Gummies for COPD: What Real-World Experience and Evidence Actually Show
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CopdCbdRespiratoryEvidence QualityAnti-Inflammatory Why This MattersCOPD affects 16 million Americans with limited therapeutic options beyond...
Dry conditions mean early start to N.B. fire season | CBC.ca
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Respiratory HealthDelivery MethodsEnvironmental HealthCopdAsthma Why This MattersWildfire smoke exposure significantly impacts respiratory health and...
In the Mix: 13 More Articles โ April 06, 2026
In the Mix โ Last 24 HoursApril 06, 2026. 13 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #25Burden of RSV-Associated Hospitalizations Highest in...
Older Adults with COPD More Likely to Receive Potentially Risky Cannabinoid Prescriptions, Study Finds
Although incident off-label oral cannabinoid use was relatively low among all older Ontarian adults, this drug class was used with greater frequency and more often in potentially concerning ways among older adults with COPD.
Older Adults with COPD Were Prescribed Synthetic Cannabinoids More Oftenโand at Higher DosesโThan Those Without the Disease
Incident synthetic oral cannabinoid use during this period occurred with significantly greater frequency among older adults with COPD (0.6%) versus older adults without COPD (0.3%), and those with COPD used these drugs for significantly longer durations and more frequently at higher doses.
Reducing severe breathlessness with dronabinol in the group of patients with severe and very severe chronic obstructive pulmonary disease (BONG): a randomised, double-blinded, placebo-controlled, crossover study in an outpatient clinic in Denmark
Cannabis-based medicine may alleviate breathlessness. This study will investigate whether dronabinol, a synthetic form of ฮ This single-centre, randomised, d…